These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 10852461)
1. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461 [TBL] [Abstract][Full Text] [Related]
2. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes. Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients. Kakko T; Jaakkola U; Raitakari OT; Kallio J Diab Vasc Dis Res; 2011 Jul; 8(3):221-8. PubMed ID: 21746772 [TBL] [Abstract][Full Text] [Related]
4. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes. Jaakkola U; Koulu M; Karvonen MK; Seppälä H; Pesonen U; Vahlberg T; Kallio J Exp Clin Endocrinol Diabetes; 2007 May; 115(5):281-6. PubMed ID: 17516289 [TBL] [Abstract][Full Text] [Related]
5. Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration. Kaarniranta K; Holopainen JM; Karvonen MK; Koulu M; Kallio J; Pesonen U; Teräsvirta M; Uusitalo H; Immonen I Acta Ophthalmol Scand; 2007 Mar; 85(2):188-91. PubMed ID: 17305733 [TBL] [Abstract][Full Text] [Related]
6. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038 [TBL] [Abstract][Full Text] [Related]
7. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients. Pettersson-Fernholm K; Karvonen MK; Kallio J; Forsblom CM; Koulu M; Pesonen U; Fagerudd JA; Groop PH; Diabetes Care; 2004 Feb; 27(2):503-9. PubMed ID: 14747236 [TBL] [Abstract][Full Text] [Related]
8. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216 [TBL] [Abstract][Full Text] [Related]
9. High frequency of Neuropeptide Y Leu7Pro polymorphism in an Iranian population and its association with coronary artery disease. Masoudi-Kazemabad A; Jamialahmadi K; Moohebati M; Mojarrad M; Dehghan-Manshadi R; Forghanifard MM; Akhlaghi S; Ferns GA; Ghayour-Mobarhan M Gene; 2012 Mar; 496(1):22-7. PubMed ID: 22289186 [TBL] [Abstract][Full Text] [Related]
10. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. Karvonen MK; Koulu M; Pesonen U; Uusitupa MI; Tammi A; Viikari J; Simell O; Rönnemaa T J Clin Endocrinol Metab; 2000 Apr; 85(4):1455-60. PubMed ID: 10770181 [TBL] [Abstract][Full Text] [Related]
11. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114 [TBL] [Abstract][Full Text] [Related]
12. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects. Ukkola O; Kesäniemi YA Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419 [TBL] [Abstract][Full Text] [Related]
13. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y. Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415 [TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study. Jaakkola U; Kakko T; Juonala M; Lehtimäki T; Viikari J; Jääskeläinen AE; Mononen N; Kähönen M; Koskinen T; Keltikangas-Järvinen L; Raitakari O; Kallio J Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776 [TBL] [Abstract][Full Text] [Related]
15. Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the prepro-neuropeptide Y. Kallio J; Pesonen U; Jaakkola U; Karvonen MK; Helenius H; Koulu M J Clin Endocrinol Metab; 2003 Jul; 88(7):3278-83. PubMed ID: 12843176 [TBL] [Abstract][Full Text] [Related]
16. Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes. Niskanen L; Voutilainen-Kaunisto R; Teräsvirta M; Karvonen MK; Valve R; Pesonen U; Laakso M; Uusitupa MI; Koulu M Exp Clin Endocrinol Diabetes; 2000; 108(3):235-6. PubMed ID: 10926322 [TBL] [Abstract][Full Text] [Related]
17. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD. Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562 [TBL] [Abstract][Full Text] [Related]
18. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY. Kallio J; Pesonen U; Karvonen MK; Kojima M; Hosoda H; Kangawa K; Koulu M J Clin Endocrinol Metab; 2001 Nov; 86(11):5348-52. PubMed ID: 11701704 [TBL] [Abstract][Full Text] [Related]
19. Nutrient intake, weight, and Leu7Pro polymorphism in prepro-neuropeptide Y in children. Karvonen MK; Ruottinen S; Koulu M; Pesonen U; Niinikoski H; Rask-Nissilä L; Simell O; Rönnemaa T J Clin Endocrinol Metab; 2006 Nov; 91(11):4664-8. PubMed ID: 16912140 [TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study. Ilveskoski E; Viiri LE; Mikkelsson J; Pörsti I; Lehtimäki T; Karhunen PJ Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]